Plaintiffs attorneys stand to make $5 million from the proposed $16.75 million settlement of a class action suit by investors against North Chicago-based drugmaker AbbVie, which alleged the company hid information that led investors to lose money after AbbVie backed out of a merger with a European company. A group of hedge funds and other… Continue reading AbbVie to Pay $16.8M in Fraud Suit Settlement
Looking For Market Distribution? Download the Media Kit
